The Korea Fund, Inc. (NYSE:KF) reported recently a portfolio manager call as part of the next Annual Meeting of Stockholders, to be held at 9:30 a.m., Eastern time, on October 27, 2010.
Sang Won Kim, lead portfolio manager of KF at RCM Asia Pacific Limited, will present an outlook of the Korean economy and stock market for 2011 during the call.
Power3 Medical Products, Inc. (PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials.
The tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
In addition, Power3 Medical Products, Inc. has recently signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc., a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.
PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger.
The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.
For more information about this company please visit http://www.power3medical.com
Convio, Inc., (NASDAQ:CNVO) recently reported the new and improved Nonprofit Live TV, and the availability of best practices guides and tip sheets on donor management, social media, fundraising, email marketing and website management.
These resources have been designed for nonprofit professionals to drive results for their organizations.
Tutor Perini Corporation (NYSE:TPC), a leading civil and building construction company, recently reported that its subsidiary, Perini Management Services, Inc. (PMSI), has been awarded $44 million worth of task orders under a previously announced Department of the Interior (DOI) multiple award task order contract (MATOC).
The contract has a $400 million ceiling over a five year period and is available to all agencies within the DOI.
Muscle Pharm Corp. (MSLP.OB) is one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in its portfolio of performance products.
Muscle Pharm Corp. top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside.
UFC star Jake Shields was wearing MSLP apparel at the UFC 121 co-main event and got the job done as he won the split decision over Martin Kampmann at UFC 121. The judges saw the fight 28-29, 30-27, 29-28 for Shields.
Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere.
Furthermore, MSLP previously entered into a distribution agreement with TapouT to launch a MusclePharm apparel line that includes t-shirts, sweat suits, shorts and other active wear items.
Also, Bodybuilding.com previously selected the Company as the Supplement Company of the Month for October.Bodybuilding.com recognizes leading supplement companies with products and services that are making a positive impact on the industry and their consumers each month.
For more information about this company please visit http://www.musclepharm.com
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings, Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).